A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback